Lenvatinib ‐associated hemoperitoneum in a patient with primary angiosarcoma of the breast

Key Clinical MessageWe highlight the risk of lenvatinib drug toxicity when high-risk anatomic regions are affected by angiosarcoma.

Source: Clinical Case Reports - March 28, 2024 Category: General Medicine Authors: Ijeoma Orabueze, Inemesit Akpan, Ryan Denley Tags: CASE REPORT Source Type: research